Bausch & Lomb to buy eyeonics

Article

Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.

Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.

Upon completion of the deal, Bausch & Lomb will absorb eyeonics' operations as part of its surgical business. Eyeonics generated approximately $34 million in revenue in 2007, a 100% increase over the prior year.

The acquisition is expected to complete within the first quarter of 2008.

Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.